Republic of Moldova vs Switzerland: Immunization, measles second dose
Republic of Moldova
93.0%
in 2024
Switzerland
93.0%
in 2024
Republic of Moldova rank
45th
Switzerland rank
45th
Immunization, measles second dose over time
- Republic of Moldova
- Switzerland
How they compare
Republic of Moldova currently reports 93.0% against 93.0% in Switzerland, a difference of 0.0%.
The two have swapped places 3 times across 20 shared years of data; in 2005 it was Republic of Moldova ahead.
Republic of Moldova ranks 45th and Switzerland ranks 45th of 178 countries.
Across the 3 decades both report, Republic of Moldova averaged higher in 2 and Switzerland in 1.
Head to head by decade
| Decade | Republic of Moldova | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 97.4% | 75.8% | 21.6% | Republic of Moldova |
| 2010s | 94.4% | 87.2% | 7.2% | Republic of Moldova |
| 2020s | 92.8% | 93.0% | 0.2% | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, measles second dose, Republic of Moldova or Switzerland?
- Republic of Moldova, at 93.0% against 93.0% in Switzerland as of 2024.
- What is the difference in immunization, measles second dose between Republic of Moldova and Switzerland?
- 0.0%, with Republic of Moldova ahead.
- How many years of comparable data are there for Republic of Moldova and Switzerland?
- 20 years are reported by both, from 2005 to 2024.
- How do Republic of Moldova and Switzerland rank globally for immunization, measles second dose?
- Republic of Moldova ranks 45th and Switzerland ranks 45th of 178 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, measles second dose (% of children by the nationally recommended age). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.